- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
NVLG
TLV
Week ended 31 Jul 2026
Weekly Investor Report
Novolog (Pharm-Up 1966) Ltd · Healthcare · Medical Distribution
Latest close
0.81 ILA
19.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -18.0% below the Trend Line and sits at 17.0% of its 52-week range. The latest completed week returned 19.6%, after a 7.8% four-week move. The latest news-sentiment score is 18/100.
Setup score
31
out of 100
Latest Close
0.81 ILA
31 Jul 2026
1W Return
19.6%
latest completed week
4W Return
7.8%
short-term follow-through
12W Return
-11.2%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
19.6%
Latest completed week; four-week move 7.8%.
Indicator stack
0/42
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.20%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
18/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -18.0% below the Trend Line and sits at 17.0% of its 52-week range. The latest completed week returned 19.6%, after a 7.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.8% over four weeks, -11.2% over 12 weeks, and -39.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.66Latest activity-pressure read.
Pressure change44.6%Four-week change in activity pressure.
Leadership-35.95Latest relative-leadership reading.
RS change18.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment18/100
Weighted news tone is negative across 1 relevant articles.
0 positive · 0 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.4%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher7 of 2617 weeks finished lower.
Best week+19.6%Week of 31 Jul.
Worst week-11.9%Week of 27 Mar.
Latest week+19.6%Week of 31 Jul.
Shape of recent returns
Strong gains5
Modest gains2
Flat weeks2
Modest losses7
Sharp losses10
Recent vol8.3%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split19/29Count of positive and negative weeks in the 52-week window.
Average skew4.7% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIL Healthcare
4-week rank4 / 50
Group average-6.0%
Trend breadth6.0%
Trend6.0%active weekly trend signals
MD18.0%positive activity pressure
RS4.0%positive relative leadership
Four-week leaders
IndustryIL Medical Distribution
4-week rank1 / 1
Group average7.8%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Next-Week ExpectancyNegative 37.20%Next-week expectancy is negative with a 37.20% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment18/100Weighted news tone is negative across 1 relevant articles.
Novolog (TASE:NVLG) One Off ₪21.7m Loss Reinforces Bearish Profitability Narratives Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 0.81 ILA | 19.6% | 0.99 ILA | 1.36 ILA | -0.66 | -35.95 | 3.6M | Off |
| 24 Jul 2026 | 0.68 ILA | -3.5% | 1.01 ILA | 1.37 ILA | -1.00 | -48.55 | 471.8K | Off |
| 17 Jul 2026 | 0.70 ILA | 5.5% | 1.03 ILA | 1.37 ILA | -0.96 | -46.24 | 3.6M | Off |
| 10 Jul 2026 | 0.67 ILA | -11.4% | 1.05 ILA | 1.38 ILA | -1.09 | -48.88 | 2.8M | Off |
| 3 Jul 2026 | 0.75 ILA | 3.6% | 1.07 ILA | 1.39 ILA | -1.19 | -44.20 | 1.1M | Off |
| 26 Jun 2026 | 0.73 ILA | -9.0% | 1.08 ILA | 1.39 ILA | -1.28 | -45.71 | 0 | Off |
| 19 Jun 2026 | 0.80 ILA | -1.6% | 1.10 ILA | 1.40 ILA | -1.12 | -42.96 | 943 | Off |
| 12 Jun 2026 | 0.81 ILA | -6.1% | 1.12 ILA | 1.41 ILA | -1.16 | -45.60 | 129.2K | Off |
| 5 Jun 2026 | 0.87 ILA | -6.1% | 1.13 ILA | 1.41 ILA | -1.17 | -42.02 | 204.4K | Off |
| 29 May 2026 | 0.92 ILA | 10.4% | 1.14 ILA | 1.41 ILA | -1.08 | -41.81 | 2.1M | Off |
| 22 May 2026 | 0.83 ILA | -1.4% | 1.16 ILA | 1.42 ILA | -1.24 | -47.37 | 555.4K | Off |
| 15 May 2026 | 0.85 ILA | -7.5% | 1.17 ILA | 1.42 ILA | -1.22 | -47.46 | 1.0M | Off |
| 8 May 2026 | 0.92 ILA | -3.7% | 1.18 ILA | 1.43 ILA | -0.99 | -45.88 | 5.3M | Off |
| 1 May 2026 | 0.95 ILA | -6.7% | 1.20 ILA | 1.43 ILA | -1.14 | -43.75 | 810.5K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.